News - Events

The pharmaceutical microbiology industry has seen many changes in recent years. From advances in methodology to regulation, the industry is becoming both more important and more complex. This meeting is an opportunity to join industry experts to discuss and analyse the latest developments. These include reviewing knowledge about the human microbiome, becoming acquainted with novel testing methods and monitoring the impact of this technology on the environment.

The market for medicines that treat pain is expected to expand at a rate of nearly 5% over the next six years with increasing numbers of people experiencing cancer, lower back pain, postsurgical pain and arthritis. This meeting will examine the products in development to treat chronic pain and how clinical trials for these indications should be designed and conducted.

Delegates will discuss case studies of drugs in preclinical and clinical development and the regulatory requirements for these therapies.

This meeting will look at all aspects of injectable drug delivery including device design, formulation, packaging and the regulatory requirements for approval. These devices are undergoing change in order to be compatible with a new generation of drugs. This conference will review market trends as well as the challenge of getting patients to comply with their treatments.

This meeting on pharmaceutical microbiology will discuss new technologies for improving processes and novel validation techniques. In addition, there will be discussions about regulatory issues such as monitoring the impact of this technology on the environment. Discussions will further cover risk-based approaches to aseptic processing and methods for preventing environmental contamination.